Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
European Journal of Medicinal Chemistry
|
September 8, 2017
Hydroxytriazole derivatives as potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors discovered by bioisosteric scaffold hopping approach
Agnese C Pippione, Alessandro Giraudo, Davide Bonanni, et al.
Microorganisms
|
August 27, 2021
The New Generation <i>h</i>DHODH Inhibitor MEDS433 Hinders the In Vitro Replication of SARS-CoV-2 and Other Human Coronaviruses
Arianna Calistri, Anna Luganini, Barbara Mognetti, et al.
Journal of Medicinal Chemistry
|
June 18, 2025
Fluorescent Isostere (<i>Fluostere</i>) of the Carboxylate: Design of <i>h</i>DHODH Fluorescent Inhibitors as Proof of Concept
Stefano Sainas, Elena Martino, Claudio Garino, et al.
European Journal of Medicinal Chemistry
|
April 21, 2022
New aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the hydroxytriazole scaffold
Agnese Chiara Pippione, Zühal Kilic-Kurt, Sandra Kovachka, et al.
Cancers
|
March 6, 2021
The Synergism between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia
Valentina Gaidano, Mohammad Houshmand, Nicoletta Vitale, et al.
Journal of Medicinal Chemistry
|
April 4, 2019
Use of the 4-Hydroxytriazole Moiety as a Bioisosteric Tool in the Development of Ionotropic Glutamate Receptor Ligands
Stefano Sainas, Piero Temperini, Jill C Farnsworth, et al.
ACS Medicinal Chemistry Letters
|
April 19, 2019
Bioisosteres of Indomethacin as Inhibitors of Aldo-Keto Reductase 1C3
Marco L Lolli, Irene M Carnovale, Agnese C Pippione, et al.
European Journal of Medicinal Chemistry
|
March 31, 2018
Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acid
Agnese Chiara Pippione, Irene Maria Carnovale, Davide Bonanni, et al.
ACS Medicinal Chemistry Letters
|
August 14, 2024
AI Based Discovery of a New AKR1C3 Inhibitor for Anticancer Applications
Agnese C Pippione, Chiara Vigato, Cristina Tucciarello, et al.
Journal of Medicinal Chemistry
|
May 24, 2019
Five-Membered N-Heterocyclic Scaffolds as Novel Amino Bioisosteres at γ-Aminobutyric Acid (GABA) Type A Receptors and GABA Transporters
Alessandro Giraudo, Jacob Krall, Francesco Bavo, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
European Journal of Medicinal Chemistry
|
September 8, 2017
Hydroxytriazole derivatives as potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors discovered by bioisosteric scaffold hopping approach
Agnese C Pippione, Alessandro Giraudo, Davide Bonanni, et al.
Microorganisms
|
August 27, 2021
The New Generation <i>h</i>DHODH Inhibitor MEDS433 Hinders the In Vitro Replication of SARS-CoV-2 and Other Human Coronaviruses
Arianna Calistri, Anna Luganini, Barbara Mognetti, et al.
Journal of Medicinal Chemistry
|
June 18, 2025
Fluorescent Isostere (<i>Fluostere</i>) of the Carboxylate: Design of <i>h</i>DHODH Fluorescent Inhibitors as Proof of Concept
Stefano Sainas, Elena Martino, Claudio Garino, et al.
European Journal of Medicinal Chemistry
|
April 21, 2022
New aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the hydroxytriazole scaffold
Agnese Chiara Pippione, Zühal Kilic-Kurt, Sandra Kovachka, et al.
Cancers
|
March 6, 2021
The Synergism between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia
Valentina Gaidano, Mohammad Houshmand, Nicoletta Vitale, et al.
Journal of Medicinal Chemistry
|
April 4, 2019
Use of the 4-Hydroxytriazole Moiety as a Bioisosteric Tool in the Development of Ionotropic Glutamate Receptor Ligands
Stefano Sainas, Piero Temperini, Jill C Farnsworth, et al.
ACS Medicinal Chemistry Letters
|
April 19, 2019
Bioisosteres of Indomethacin as Inhibitors of Aldo-Keto Reductase 1C3
Marco L Lolli, Irene M Carnovale, Agnese C Pippione, et al.
European Journal of Medicinal Chemistry
|
March 31, 2018
Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acid
Agnese Chiara Pippione, Irene Maria Carnovale, Davide Bonanni, et al.
ACS Medicinal Chemistry Letters
|
August 14, 2024
AI Based Discovery of a New AKR1C3 Inhibitor for Anticancer Applications
Agnese C Pippione, Chiara Vigato, Cristina Tucciarello, et al.
Journal of Medicinal Chemistry
|
May 24, 2019
Five-Membered N-Heterocyclic Scaffolds as Novel Amino Bioisosteres at γ-Aminobutyric Acid (GABA) Type A Receptors and GABA Transporters
Alessandro Giraudo, Jacob Krall, Francesco Bavo, et al.
Page
of 6